A Multi-Centric, Single-Blinded, Randomized, Parallel-Group Study to Evaluate the Effectiveness of Nasoalveolar Moulding Treatment in Non-Syndromic Patients with Complete Unilateral Cleft Lip, Alveolus and Palate (NAMUC Study): a Study Protocol for a Randomized Controlled Trial.

Badri Thiruvenkatachari,Krishnamurthy Bonanthaya, Anne Marie Kuijpers Jagtman,Jonathan Sandler, Rajesh S Powar,Syed Altaf Hussain,B. Subramaniyan, Nitin Bhola,Hari Kishore Bhat, Varun Ramachandra, Sylvia Jayakumar,Puneet Batra, Subhiksha Chakkaravarthi, V. Thailavathy, Manoj Prathap, Thulasiram Elumalai,Karthika Nambiar,Charanya Vijayakumar,Ravi Kumar Mahajan,Sundereshwer Chander Sood,Sukhdeep Singh Kahlon, Shruti Bijapur,Ranjit Haridas Kamble, K. M. Keluskar, Amit Nilgar,Faizan Ahmed Khan, Devika Das, Swetha Sridhar, Adrija Buch,Shuba Kumar,Rani Mohanraj,Stefan Listl, Samiksha Chopra, Vikrant Jadhav,Anika Arora, Chintan Valiya, Madhuri Pattamata

Trials（2024）

引用 0|浏览0

暂无评分

摘要

Cleft lip and palate (CLP) are among the most common congenital anomaly that affects up to 33,000 newborns in India every year. Nasoalveolar moulding (NAM) is a non-surgical treatment performed between 0 and 6 months of age to reduce the cleft and improve nasal aesthetics prior to lip surgery. The NAM treatment has been a controversial treatment option with 51 https://ctri.nic.in/Clinicaltrials/advsearch.php —use the search boxes by entering the following details: Interventional trial > November 2022 > NAMUC).

查看译文

关键词

Randomized controlled trials,Cleft lip and palate,Nasoalveolar moulding,NAM treatment,CLP,PSIO,Presurgical infant orthopaedics

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要